Odabaş ME, Ertürk M, Cinar C, Tüzüner T, Tulunoğlu O. Cytotoxicity of a new hemostatic agent on human pulp fibroblasts in vitro. Med Oral Patol Oral Cir Bucal. 2011 Jul 1;16 (4):e584-7.  

 

doi:10.4317/medoral.16.e584

http://dx.doi.org/doi:10.4317/medoral.16.e584

 

 

1. Tziafas D. The future role of a molecular approach to pulp-dentinal regeneration. Caries Res. 2004;38:314-20.
doi:10.1159/000077771
PMid:15153705

2. Stanley HR. Pulp capping: conserving the dental pulp--can it be done? Is it worth it? Oral Surg Oral Med Oral Pathol. 1989;68:628-39.
doi:10.1016/0030-4220(89)90252-1

3. Schröder U. Effect of an extra-pulpal blood clot on healing following experimental pulpotomy and capping with calcium hydroxide. Odontol Revy. 1973;24:257-68.
PMid:4518199

4. Goker H, Haznedaroglu IC, Ercetin S, Kirazli S, Akman U, Ozturk Y, et al. Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper. J Int Med Res. 2008;36:163-70.
PMid:18304416

5. Meric Teker A, Korkut AY, Kahya V, Gedikli O. Prospective, randomized, controlled clinical trial of Ankaferd Blood Stopper in patients with acute anterior epistaxis. Eur Arch Otorhinolaryngol. 2010;267:1377-81.
doi:10.1007/s00405-010-1208-0
PMid:20155359

6. Teker AM, Korkut AY, Gedikli O, Kahya V. Prospective, controlled clinical trial of Ankaferd Blood Stopper in children undergoing tonsillectomy. Int J Pediatr Otorhinolaryngol. 2009;73:1742-5.
doi:10.1016/j.ijporl.2009.09.029
PMid:19836089

7. Tuncer I, Doganay L, Ozturk O. Instant control of fundal variceal bleeding with a folkloric medicinal plant extract: Ankaferd Blood Stopper. Gastrointest Endosc. 2010;71:873-5.
doi:10.1016/j.gie.2009.08.021
PMid:19922917

8. Kurt M, Disibeyaz S, Akdogan M, Sasmaz N, Aksu S, Haznedaroglu IC. Endoscopic application of ankaferd blood stopper as a novel experimental treatment modality for upper gastrointestinal bleeding: a case report. Am J Gastroenterol. 2008;103:2156-8.
doi:10.1111/j.1572-0241.2008.01982_15.x
PMid:18796123

9. Kurt M, Kacar S, Onal IK, Akdogan M, Haznedaroglu IC. Ankaferd Blood Stopper as an effective adjunctive hemostatic agent for the management of life-threatening arterial bleeding of the digestive tract. Endoscopy. 2008;40 Suppl 2:E262.
doi:10.1055/s-2008-1077648
PMid:19090459

10. Ibis M, Kurt M, Onal IK, Haznedaroglu IC. Successful management of bleeding due to solitary rectal ulcer via topical application of Ankaferd blood stopper. J Altern Complement Med. 2008;14:1073-4.
doi:10.1089/acm.2008.0314
PMid:19055332

11. Cipil HS, Kosar A, Kaya A, Uz B, Haznedaroglu IC, Goker H, et al. In vivo hemostatic effect of the medicinal plant extract Ankaferd Blood Stopper in rats pretreated with warfarin. Clin Appl Thromb Hemost. 2009;15:270-6.
doi:10.1177/1076029608329578
PMid:19117967

12. Mjör IA. Biologic assessment of restorative dental materials: interrelationship of biologic and technologic properties. Oper Dent. 1978;3:9-13.
PMid:112585

13. Feigal RJ, Yesilsoy C, Messer HH, Nelson J. Differential sensitivity of normal human pulp and transformed mouse fibroblasts to cytotoxic challenge. Arch Oral Biol. 1985;30:609-13.
doi:10.1016/0003-9969(85)90081-0

14. Van Wyk CW, Olivier A, Maritz JS. Cultured pulp fibroblasts: are they suitable for in vitro cytotoxicity testing? J Oral Pathol Med. 2001;30:168-77.
doi:10.1034/j.1600-0714.2001.300307.x
PMid:11271632

15. Chang YC, Huang FM, Cheng MH, Chou LS, Chou MY. In vitro evaluation of the cytotoxicity and genotoxicity of root canal medicines on human pulp fibroblasts. J Endod. 1998;24:604-6.
doi:10.1016/S0099-2399(98)80119-2

16. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55-63.
doi:10.1016/0022-1759(83)90303-4

17. Yamamura T. Differentiation of pulpal cells and inductive influences of various matrices with reference to pulpal wound healing. J Dent Res. 1985;64:530-40.
PMid:3857253

18. Thomas GP, Boyd JB, Soni NN, Palmer JE. Histologic study of pulp capping using chlorhexidine in dogs. NDA J. 1995;46:17-20.
PMid:9594063

19. Fei AL, Udin RD, Johnson R. A clinical study of ferric sulfate as a pulpotomy agent in primary teeth.
Pediatr Dent. 1991;13:327-32.
PMid:1843987

20. Accorinte Mde L, Loguercio AD, Reis A, Muench A, de Araújo VC.
Response of human pulp capped with a bonding agent after bleeding control with hemostatic agents. Oper Dent. 2005;30:147-55.
PMid:15853098

21. Hafez AA, Cox CF, Tarim B, Otsuki M, Akimoto N. An in vivo evaluation of hemorrhage control using sodium hypochlorite and direct capping with a one- or two-component adhesive system in exposed nonhuman primate pulps. Quintessence Int. 2002;33:261-72.
PMid:11989375

22. Tunç ES, Saroğlu I, Sari S, Günhan O. The effect of sodium hypochlorite application on the success of calcium hydroxide pulpotomy in primary teeth. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;102:e22-6.
doi:10.1016/j.tripleo.2005.12.013
PMid:16876040

23. Costa CA, Edwards CA, Hanks CT. Cytotoxic effects of cleansing solutions recommended for chemical lavage of pulp exposures. Am J Dent. 2001;14:25-30.
PMid:11806475

24. Heling I, Rotstein I, Dinur T, Szwec-Levine Y, Steinberg D. Bactericidal and cytotoxic effects of sodium hypochlorite and sodium dichloroisocyanurate solutions in vitro. J Endod. 2001;27:278-80.
doi:10.1097/00004770-200104000-00009
PMid:11485267

25. Larson PO. Topical hemostatic agents for dermatologic surgery. J Dermatol Surg Oncol. 1988;14:623-32.
PMid:3286706

26. Lemon RR, Steele PJ, Jeansonne BG. Ferric sulfate hemostasis: effect on osseous wound healing. Left in situ for maximum exposure.
J Endod. 1993;19:170-3.
doi:10.1016/S0099-2399(06)80681-3

27. De Menezes JV, Takamori ER, Bijella MF, Granjeiro JM.
In vitro toxicity of MTA compared with other primary teeth pulpotomy agents. J Clin Pediatr Dent. 2009;33:217-21.
PMid:19476094

28. Peng L, Ye L, Guo X, Tan H, Zhou X, Wang C, et al. Evaluation of formocresol versus ferric sulphate primary molar pulpotomy: a systematic review and meta-analysis. Int Endod J. 2007;40:751-7.
doi:10.1111/j.1365-2591.2007.01288.x
PMid:17714467

29. Tomizawa Y, Komori M, Takada K, Nishida H, Endo M, Kurosawa H. In Vitro and In Vivo Evaluation of the Biocompatibility and Cytotoxicity of Local Hemostatic Agents. Jpn J Car-diovasc Surg. 2004;33:382-6.

30. Darmani H, Al-Hiyasat AS, Milhem MM. Cytotoxicity of dental composites and their leached components. Quintessence Int. 2007;38:789-95.
PMid:17873986